CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients
Clinical trial NCT04195945 · COMPLETED
Trial details
- NCT number
- NCT04195945
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-27
- Primary completion
- 2025-06-06
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.